Cutaneous adverse drug reactions reported in children: A national register-based study

British Journal of Dermatology

Volumn 168, Issue 2, 2013, Pages 434-437

  Aagaard, L ^a,b   Hansen, E H ^b,c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Danish Pharmacovigilance Research Project (DANPREP)   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN; ARTICAINE; AZITHROMYCIN; CHICKENPOX VACCINE; DICLOXACILLIN; DIPHTHERIA VACCINE; ENCEPHALITIS VACCINE; ERYTHROMYCIN; FENTANYL; FLUCLOXACILLIN; FLUCONAZOLE; FLUMETASONE; FUSIDIC ACID; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IRRESA; LAMOTRIGINE; LYMECYCLINE; MENINGITIS VACCINE; MEPIVACAINE; OFLOXACIN; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; SULFAMETHOXAZOLE; TETANUS TOXOID; TRIMETHOPRIM; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VERUCID; WART VIRUS VACCINE;

ADVERSE DRUG REACTION; ANGIONEUROTIC EDEMA; CUTANEOUS ADVERSE DRUG REACTION; DRUG ERUPTION; ERYTHEMA; ERYTHEMA MULTIFORME; GROUPS BY AGE; HOSPITALIZATION; HUMAN; LETTER; LICHEN PLANUS; LIVEDO RETICULARIS; MORTALITY; PETECHIA; PRIORITY JOURNAL; SCABIES; SKIN ALLERGY; SYSTEMIC THERAPY; URTICARIA; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; DENMARK; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; REGISTRIES;

EID: 84873123529     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11133.x     Document Type: Letter

References (12)

1. Aagaard L, Christensen A, Hansen EH,. Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol 2010; 70: 481-91.
2. Segal AR, Doherty KM, Leggott J, et al,. Cutaneous reactions to drugs in children. Pediatrics 2007; 120: e1082-96.
3. Star K, Noren NG, Edwards IR,. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf 2011; 34: 415-28.
4. Naldi L, Conforti A, Venegoni M, et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48: 839-46.
5. Castro-Pastrana LI, Ghannadan R, Reider MJ, et al. Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian Pharmacogenomics Network for Drug Safety (CPNDS). J Popul Ther Clin Pharmacol 2011; 18: e106-20.
6. Sekula P, Liss Y, Davidovici B, et al. Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study. J Burn Care Res 2011; 32: 237-45.
7. Aagaard L, Weber CB, Hansen EH,. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf 2010; 33: 327-39.
8. World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC Classification Index with DDDs, 2008. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2011.
9. European Commission. The EU Pharmacovigilance System. Pharmaceuticals: Medicinal Products for Human use and Medical Products for Veterinary use. Available at: http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/homev9.htm (last accessed 23 July 2012).
10. Gomes RE, Fonseca J, Araujo L, et al,. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy 2008; 38: 191-8.
11. Heinzerling LM, Tomsitz D, Anliker MD,. Is drug allergy less prevalent than previously assumed? A 5-year analysis Br J Dermatol 2012; 166: 107-14.
12. Lopez-Gonzalez E, Herdeiro MT, Figueiras A,. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009; 32: 19-31.